Skip to main content
    V

    Veracyte Inc (VCYT)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $24.23
    +0.22 (+0.92%)

    Market Cap: $1.94B

    Last updated: Nov 17, 2026 at 5:47 PM ET

    Veracyte Inc (VCYT) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Veracyte (VCYT) has a latest price of $24.23 on Nov 17, 2026, 60.2% below its 52-week high of $60.91. Its price fell 38.4% over the past 12 months. The month-end price rose 588.8% over the 10 years through Oct 2026, a compound annual rate of 21.3%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $58.73 in Jun 2026 and its lowest $5.56 in Mar 2018, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart VCYT with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VCYT.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 42.6%, and over 6 months it fell 41.9%. The month-end price rose 141.4% over the 3 years through Oct 2026, a compound annual rate of 34.1%.

    PeriodChange
    1 month-44.7%
    3 months-42.6%
    6 months-41.9%
    12 months-38.4%
    12 months, with dividends-38.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+141.4%+34.1%
    5 years+4.4%+0.9%
    10 years+588.8%+21.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 121.9%, and its weakest was 2022, when it fell 42.4%.

    YearCloseChange
    2026 through Oct 2026$50.01+18.8%
    2025$42.10+6.3%
    2024$39.60+43.9%
    2023$27.51+15.9%
    2022$23.73-42.4%
    2021$41.20-15.8%
    2020$48.94+75.3%
    2019$27.92+121.9%
    2018$12.58+92.6%
    2017$6.53-15.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 41.5% below its 50-day average of $41.43 and 42.6% below its 200-day average of $42.24.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$24.23
    52-week high$60.91-60.2%
    52-week low$21.91+10.6%
    50-day average$41.43-41.5%
    200-day average$42.24-42.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 60.3%.

    MeasureValue
    1-year beta3.19
    Largest fall, 1 year-60.3%
    Largest fall, 3 years-60.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About VCYT

    What is VCYT's 1-year price change?

    Veracyte's price fell 38.4% over the past 12 months. With dividends included, the 12-month total return was -38.4%.

    What is VCYT's 5-year price change?

    Veracyte's month-end price rose 4.4% over the 5 years through Oct 2026, a compound annual rate of 0.9%. These figures leave out dividends.

    What is VCYT's 52-week high and low?

    Veracyte's 52-week high is $60.91 and its 52-week low is $21.91. Its latest price of $24.23 on Nov 17, 2026 is 60.2% below the high.

    What is VCYT's beta?

    Veracyte's 1-year beta against the S&P 500 is 3.19, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 60.3%.

    Is the VCYT chart free?

    Yes. Advanced Charting for VCYT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.